Literature DB >> 28744675

Potentially inappropriate medication at hospital admission in patients with palliative care needs.

Daniel Sevilla-Sánchez1, Núria Molist-Brunet2, Jordi Amblàs-Novellas2, Joan Espaulella-Panicot2,3, Carles Codina-Jané4,5.   

Abstract

Background Potentially inappropriate medications (PIMs) are common in older patients with polypharmacy, and are related to negative clinical results. Little information is available on the characteristics and consequences of PIMs in patients with advanced chronic conditions and palliative care needs. Objective To evaluate, for this population: (i) the prevalence of PIMs; (ii) the possible risk factors associated with its onset; and (iii) the related clinical consequences. Setting Acute-hospital care Geriatric Unit (AGU) in County of Osona, Spain. Method Ten-month prospective cross-sectional study. Patients with palliative care needs were identified according to the NECPAL CCOMS-ICO® test. Upon hospital admission, a multidisciplinary team consisting of a pharmacist and two AGU physicians determined the PIMs of the routine chronic medication of the patients. Sociodemographic and pharmacological data were collected with the objective of determining possible risk factors related to the existence of PIMs. Main outcome measure Prevalence and type of PIMs according to STOPP version 2 and MAI criteria at the time of hospital admission. Furthermore, days of hospital admission, destination at hospital discharge and survival analysis at 12 months related to PIMs were evaluated. Results Two hundred thirty-five patients (mean age 86.80, SD 5.37; 65.50% women) were recruited. According to the STOPP criteria, 88.50% of patients had ≥1 criterion (mainly 'indication of medication', followed by those that affect the nervous system and psychotropic drugs and risk drugs in people suffering from falls), and according to the MAI tool, 97.40% of the patients had some criterion related to inappropriate medication (mainly, duration of therapy). The following conditions were identified as risk factors for the existence of PIMs: insomnia, anxiety-depressive disorder, falls, pain, excessive polypharmacy and therapeutic complexity. There were no differences among patients in days of hospital stay, discharge's destination or survival at 12 months, regardless of the tool used. Conclusion The presence of PIMs is high in patients requiring palliative care. Some potentially modifiable risk factors such as the pharmacological ones are associated with a greater presence of inappropriate medication. The presence of PIMs does not affect this population in terms of mortality.

Entities:  

Keywords:  Chronic disease; MAI; Medication Appropriateness Index; NECPAL; Palliative care; Polypharmacy; Potentially inappropriate medication; STOPP criteria; Spain

Mesh:

Year:  2017        PMID: 28744675     DOI: 10.1007/s11096-017-0518-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


  47 in total

1.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

2.  [Potentially inappropriate medication on admission to a medium-stay unit according to STOPP and START criteria].

Authors:  Daniel Sevilla-Sánchez; Joan Espaulella-Panicot; Ana María de Andrés-Lazaro; Rosa Torres-Allezpuz; Montserrat Soldevila-Llagostera; Carles Codina-Jane
Journal:  Rev Esp Geriatr Gerontol       Date:  2012-06-02

3.  Estimating 1-Year Mortality for High-Risk Primary Care Patients Using the "Surprise" Question.

Authors:  Joshua R Lakin; Margaret G Robinson; Rachelle E Bernacki; Brian W Powers; Susan D Block; Rebecca Cunningham; Ziad Obermeyer
Journal:  JAMA Intern Med       Date:  2016-12-01       Impact factor: 21.873

4.  Global measures: utility in defining and measuring treatment response in dementia.

Authors:  Barry Reisberg
Journal:  Int Psychogeriatr       Date:  2007-06       Impact factor: 3.878

5.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

Authors:  P Gallagher; C Ryan; S Byrne; J Kennedy; D O'Mahony
Journal:  Int J Clin Pharmacol Ther       Date:  2008-02       Impact factor: 1.366

Review 6.  Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review.

Authors:  Eline Tommelein; Els Mehuys; Mirko Petrovic; Annemie Somers; Pieter Colin; Koen Boussery
Journal:  Eur J Clin Pharmacol       Date:  2015-09-26       Impact factor: 2.953

7.  Medication use and potentially inappropriate medications in those with limited prognosis living in residential aged care.

Authors:  Claire Patricia Heppenstall; Joanna B Broad; Michal Boyd; Joanna Hikaka; Xian Zhang; Julia Kennedy; Martin J Connolly
Journal:  Australas J Ageing       Date:  2015-09-28       Impact factor: 2.111

8.  A comparison of beers and STOPP criteria in assessing potentially inappropriate medications in nursing home residents attending the emergency department.

Authors:  Anne R Grace; Robert Briggs; Ruth E Kieran; Roisin M Corcoran; Roman Romero-Ortuno; Tara L Coughlan; Desmond O'Neill; Rónán Collins; Sean P Kennelly
Journal:  J Am Med Dir Assoc       Date:  2014-10-07       Impact factor: 4.669

9.  Potentially inappropriate medications and functional decline in elderly hospitalized patients.

Authors:  Andrea Corsonello; Claudio Pedone; Fabrizia Lattanzio; Maria Lucchetti; Sabrina Garasto; Massimo Di Muzio; Sergio Giunta; Graziano Onder; Angelo Di Iorio; Stefano Volpato; Francesco Corica; Chiara Mussi; Raffaele Antonelli Incalzi
Journal:  J Am Geriatr Soc       Date:  2009-04-17       Impact factor: 5.562

10.  Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study.

Authors:  Khedidja Hedna; Katja M Hakkarainen; Hanna Gyllensten; Anna K Jönsson; Max Petzold; Staffan Hägg
Journal:  Eur J Clin Pharmacol       Date:  2015-09-26       Impact factor: 2.953

View more
  6 in total

1.  Hospital readmissions, mortality and potentially inappropriate prescribing: a retrospective study of older adults discharged from hospital.

Authors:  David Counter; James W T Millar; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2018-05-22       Impact factor: 4.335

2.  Potentially inappropriate medications according to STOPP-J criteria and risks of hospitalization and mortality in elderly patients receiving home-based medical services.

Authors:  Chi-Hsien Huang; Hiroyuki Umegaki; Yuuki Watanabe; Hiroko Kamitani; Atushi Asai; Shigeru Kanda; Hideki Nomura; Masafumi Kuzuya
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

3.  Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.

Authors:  Marisa Baré; Susana Herranz; Rosa Jordana; Maria Queralt Gorgas; Sara Ortonobes; Daniel Sevilla; Elisabet De Jaime; Olatz Ibarra; Candelaria Martín
Journal:  BMJ Open       Date:  2020-01-26       Impact factor: 2.692

4.  Factors associated to potentially inappropriate prescribing in older patients according to STOPP/START criteria: MoPIM multicentre cohort study.

Authors:  Marisa Baré; Marina Lleal; Sara Ortonobes; Maria Queralt Gorgas; Daniel Sevilla-Sánchez; Nuria Carballo; Elisabet De Jaime; Susana Herranz
Journal:  BMC Geriatr       Date:  2022-01-11       Impact factor: 3.921

5.  Medication regimen complexity on hospital admission in patients with advanced chronic conditions in need of palliative care.

Authors:  Daniel Sevilla-Sanchez; Núria Molist-Brunet; Javier González-Bueno; Núria Solà-Bonada; Jordi Amblàs-Novellas; Joan Espaulella-Panicot; Carles Codina-Jane
Journal:  Eur J Hosp Pharm       Date:  2018-04-26

Review 6.  Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: A systematic review and meta-analysis.

Authors:  Alemayehu B Mekonnen; Bernice Redley; Barbora de Courten; Elizabeth Manias
Journal:  Br J Clin Pharmacol       Date:  2021-05-18       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.